Complementary and alternative medicine use among cancer patients at the end of life: Korean national study

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1419-1424

  Choi, Jin Young ^a   Chang, Yoon Jung ^a   Hong, Young Seon ^b   Heo, Dae Seog ^c   Kim, Samyong ^d   Lee, Jung Lim ^e   Choi, Jong Soo ^f   Kang, Ki Mun ^g   Kim, Si Young ^h   Jeong, Hyun Sik ⁱ   Lee, Chang Geol ^j   Choi, Youn Seon ^k   Lim, Ho Yeong ^l   Yun, Young Ho ^c  

^a National Cancer Center   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Chungnam National University College of Medicine   (South Korea)

^e Fatima Hospital   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Gyeongsang National University   (South Korea)

^h Kyung Hee University College of Medicine   (South Korea)

ⁱ Good Samaritan Hospital   (South Korea)

^j Yonsei University College of Medicine   (South Korea)

^k Korea University College of Medicine   (South Korea)

^l Samsung Medical Center   (South Korea)

more..

Author keywords

Complementary and alternative medicine; End of life; Korean cancer patients

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; DOCTOR PATIENT RELATION; ECONOMICS; FEMALE; HEALTH CARE SURVEY; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PATIENT ATTITUDE; PATIENT SATISFACTION; QUESTIONNAIRE; SOUTH KOREA; STATISTICAL MODEL; STATISTICS; TERMINAL CARE; TIME; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; DISCLOSURE; FEMALE; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; REPUBLIC OF KOREA; TERMINAL CARE; TIME FACTORS;

EID: 84873054442     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1419     Document Type: Article

References (39)

1. Ang-Lee MK, Moss J, Yuan CS (2001). Herbal medicines and perioperative care. JAMA, 286, 208-16.
2. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999). Use of alternative medicine by women with early-stage breast cancer. N Engl J Med, 340, 1733-9.
3. Downer SM, Cody MM, McCluskey P, et al (1994). Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ, 309, 86-9.
4. Ernst E (1998). Harmless herbs? A review of the recent literature. Am J Med, 104, 170-8.
5. Fernandez CV, Stutzer CA, MacWilliam L, et al (1998). Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol, 16, 1279-86.
6. Hyodo I, Amano N, Eguchi K, et al (2005). Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol, 23, 2645-54.
7. Kao GD, Devine P (2000). Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer, 88, 615-9.
8. Lafferty WE, Downey L, McCarty RL, et al (2006). Evaluating CAM treatment at the end of life: a review of clinical trials for massage and meditation. Complement Ther Med, 14, 100-12.
9. Lerner IJ, Kennedy BJ (1992). The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin, 42, 181-91.
10. Martin-Facklam M, Kostrzewa M, Schubert F, et al(2002). Quality markers of drug information on the Internet: an evaluation of sites about St. John's wort. Am J Med, 113, 740-5.
11. McEachrane-Gross FP, Liebschutz JM, Berlowitz D (2006). Use of selected complementary and alternative medicine (CAM) treatments in veterans with cancer or chronic pain: a cross-sectional survey. BMC Complement Altern Med, 6, 34.
12. McPherson CJ, Addington-Hall JM (2003). Judging the quality of care at the end of life: can proxies provide reliable information? Soc Sci Med, 56, 95-109.
13. Molassiotis A, Fernandez-Ortega P, Pud D, et al (2005). Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med, 13, 251-7.
14. Morris KT, Johnson N, Homer L, et al (2000). A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg, 179, 407-11.
15. Munstedt K, Kirsch K, Milch W, et al (1996). Unconventional cancer therapy-survey of patients with gynaecological malignancy. Arch Gynecol Obstet, 258, 81-8.
16. Navo MA, Phan J, Vaughan C, et al (2004). An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol, 22, 671-7.
17. Newell S, Sanson-Fisher RW (2000). Australian oncologists' self-reported knowledge and attitudes about nontraditional therapies used by cancer patients. Med J Aust, 172, 110-3.
18. Pan CX, Morrison RS, Ness J, et al (2000). Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage, 20, 374-87.
19. Richardson MA (1999). Research of complementary/ alternative medicine therapies in oncology: promising but challenging. J Clin Oncol, 17, 38-43.
20. Richardson MA, Masse LC, Nanny K, et al (2004). Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer, 12, 797-804.
21. Richardson MA, Sanders T, Palmer JL, et al(2000). Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol, 18, 2505-14.
22. Richardson MA, Straus SE (2002). Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol, 29, 531-45.
23. Risberg T, Lund E, Wist E, et al (1995). The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. Eur J Cancer, 31A, 1785-9.
24. Risberg T, Vickers A, Bremnes RM, et al (2003). Does use of alternative medicine predict survival from cancer? Eur J Cancer, 39, 372-7.
25. Robotin MC, Penman AG (2006). Integrating complementary therapies into mainstream cancer care: which way forward? Med J Aust, 185, 377-9.
26. Schraub S (2000). Unproven methods in cancer: a worldwide problem. Support Care Cancer, 8, 10-5.
27. Sollner W, Maislinger S, DeVries A, et al(2000). Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer, 89, 873-80.
28. Sollner W, Zingg-Schir M, Rumpold G, et al(1998). Need for supportive counselling-the professionals' versus the patients' perspective. A survey in a representative sample of 236 melanoma patients. Psychother Psychosom, 67, 94-104.
29. Spiegel D, Bloom JR, Kraemer HC, et al(1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2, 888-91.
30. Steinhauser KE, Christakis NA, Clipp EC, et al(2000). Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA, 284, 2476-82.
31. Swisher EM, Cohn DE, Goff BA, et al (2002). Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol, 84, 363-7.
32. Tas F, Ustuner Z, Can G, et al (2005). The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol, 44, 161-7.
33. Tasaki K, Maskarinec G, Shumay DM, et al(2002). Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology, 11, 212-20.
34. Tilden VP, Drach LL, Tolle SW (2004). Complementary and alternative therapy use at end-of-life in community settings. J Altern Complement Med, 10, 811-7.
35. Verhoef MJ, Balneaves LG, Boon HS, et al(2005). Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther, 4, 274-86.
36. Vitetta L, Sali A (2006). Complementary medicine in palliative care. Aust Fam Physician, 35, 783.
37. Wall L (2003). Fish oil supplementation in patients with advanced cancer. J Clin Oncol, 21, 3545; author reply -6.
38. WHO (2007). WHO traditional medicine strategy 2002-2005.
39. Wilkinson S, Gomella LG, Smith JA, et al (2002). Attitudes and use of complementary medicine in men with prostate cancer. J Urol, 168, 2505-9.